Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2003
08/07/2003US20030147866 Novel BGP compounds for therapy and diagnosis and methods for using same
08/07/2003US20030147864 Antisense modulation of CD36L1 expression
08/07/2003US20030147863 Antisense modulation of TFAP2C expression
08/07/2003US20030147862 Administering a colony stimulating factor and/or a nucleic acids encoding the factor; treating a vascular tumor
08/07/2003US20030147861 Compounds and methods for the modulation of immune responses
08/07/2003US20030147860 A mixture of animal growth factors, hyaluronic acid, chitosan or chitosan derivatives for treating bone disorders or filling a bone defect
08/07/2003US20030147855 Using a recombinant adeno-associated virus (rAAV) vector; useful for treating obesity and diabetes
08/07/2003US20030147853 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions
08/07/2003US20030147852 Toxin-phage bacteriocide antibiotic and uses thereof
08/07/2003US20030147851 Polypeptides and fusion proteins, useful as anticarcinogenic agent
08/07/2003US20030147850 Composition and methods for potentiating therapeutic effects of interferons
08/07/2003US20030147849 Topical formulations for delivery of interleukin-11
08/07/2003US20030147847 Isolated nucleic acid encoding a protein comprising a glycosylphosphatidyl inositol-1 polypeptide can enhance the cytolytic activity of peripheral blood mononuclear cells
08/07/2003US20030147846 Methods of using macrophage inflammatory protein-4 (MIP-4) and myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides
08/07/2003US20030147831 Hair follicle growth
08/07/2003US20030147806 PSCA: prostate stem cell anitgen and uses thereof
08/07/2003CA2474871A1 Furanone derivatives
08/07/2003CA2474821A1 Anti-viral compounds
08/07/2003CA2474807A1 Transport peptides and uses therefor
08/07/2003CA2474788A1 Compositions and methods for modulating connexin hemichannels
08/07/2003CA2474777A1 Adenoviral vectors for modulating the cellular activities associated with pods
08/07/2003CA2474759A1 Gene for peripheral arterial occlusive disease
08/07/2003CA2474723A1 Bioactive keratin peptides
08/07/2003CA2474719A1 Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
08/07/2003CA2474689A1 Drugs ameliorating circadian rhythum disorder
08/07/2003CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003CA2474620A1 Helicobacter pylori adhesion inhibitor
08/07/2003CA2474590A1 Treatment of male sexual dysfunction
08/07/2003CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003CA2474497A1 Compositions and methods related to tim-3, a th1-specific cell surface molecule
08/07/2003CA2474414A1 Oligonucleotides comprising alternating segments and uses thereof
08/07/2003CA2474316A1 Kappa-pviia-related conotoxins as organ protectants
08/07/2003CA2474006A1 Variants of the alpha 1 subunit of human ampk
08/07/2003CA2473990A1 Modulation of type ii.beta. phosphoinositide phosphate kinase
08/07/2003CA2473987A1 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
08/07/2003CA2473810A1 Fgfr agonists
08/07/2003CA2473128A1 Genetic polymorphisms in the preprotachykinin gene
08/07/2003CA2472296A1 Fap-activated anti-tumor compounds
08/07/2003CA2472242A1 Cyclosporin-containing sustained release pharmaceutical composition
08/07/2003CA2466228A1 Method for treating diseases with omega interferon
08/07/2003CA2466025A1 Rsv proteins, antibodies, compositions, methods and uses
08/07/2003CA2465265A1 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli
08/07/2003CA2464869A1 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases
08/07/2003CA2463000A1 Vesicle-associated proteins
08/07/2003CA2462216A1 Antigen panels and methods of using the same
08/06/2003EP1333094A2 Human telomerase catalytic subunit
08/06/2003EP1333090A1 Prionprotein-specific aptamers
08/06/2003EP1333088A1 Paramyxovirus vectors for introducing foreign genes into skeletal muscle
08/06/2003EP1333036A1 Peg-modified erythropoietin
08/06/2003EP1333034A1 Use of angiotensin II analogs in tissue repair
08/06/2003EP1333033A1 FAP-activated anti-tumor compounds
08/06/2003EP1333024A1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof
08/06/2003EP1332762A1 Method of treating hyperprolactinemia and prolactinomas
08/06/2003EP1332761A1 Agonists of fibroblast growth factor receptors (FGFR)
08/06/2003EP1332760A1 Novel epitopes for celiac disease and autoimmune diseases, methods for detecting those and novel non-antigenic food compounds
08/06/2003EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression
08/06/2003EP1332368A2 Methods for detecting the efficacy of anticancer treatments
08/06/2003EP1332363A1 Detection of neurodegenerative disorders
08/06/2003EP1332224A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung
08/06/2003EP1332209A2 Collections of repeat proteins comprising repeat modules
08/06/2003EP1332206A1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
08/06/2003EP1332159A1 Process for the preparation of latent antithrombin iii
08/06/2003EP1332157A2 Prokineticin polypeptides, related compositions and methods
08/06/2003EP1332152A1 Peptide ligands for prostate specific antigen
08/06/2003EP1331950A1 Methods and compositions for nucleic acid delivery
08/06/2003EP1331949A2 Method for inducing apoptiosis
08/06/2003EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation
08/06/2003EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2
08/06/2003EP1331931A2 Treatment of tinnitus
08/06/2003EP1331930A2 Methods and compositions for regulating memory consolidation
08/06/2003EP1189929B1 Factor viia inhibitors
08/06/2003EP1162945B1 Particle based vaccine composition
08/06/2003EP1146794B1 A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance
08/06/2003EP1105051A4 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing
08/06/2003EP1098664B1 Conjugates for treating inflammatory disorders and associated tissue damage
08/06/2003EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds
08/06/2003EP1015570A4 Fibrin microbeads and uses thereof
08/06/2003EP0985052B1 Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases
08/06/2003EP0973499B1 Diffusional implantable delivery system
08/06/2003EP0914148B1 Treatment of partial growth hormone insensitivity syndrome
08/06/2003EP0880358B1 Inhibitors of cyclophilin rotamase activity
08/06/2003EP0804465B1 Novel elastase inhibitors
08/06/2003EP0788557A4 Rapid detection and identification of nucleic acid variants and pathogens
08/06/2003EP0728018B1 New enzymes and prodrugs for ADEPT
08/06/2003EP0702563B1 Compositions and methods for treating cancer and hyperproliferative disorders
08/06/2003EP0687182B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus
08/06/2003CN1434870A Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434831A Improvments in or relating to immune responses to HIV
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434803A Cyclic lactams as inhibitors os A-alpha protein production
08/06/2003CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm
08/06/2003CN1434727A Anglogenesis and vascular permeability modulators and inhibitors
08/06/2003CN1434726A Multivalent platform molecules comprising high molecular weight polyethylene oxide
08/06/2003CN1434725A Amphiphilic polymers and polypeptide conjugates comprising same
08/06/2003CN1434723A Immunostimulatory oligodeoxynucleotides
08/06/2003CN1434722A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/06/2003CN1434721A Medicinal compositions for preventing and treating hemorrhagic diseases associating thrombopathy
08/06/2003CN1434720A Medicinal compositions for treating and preventing diseases based on abnormal blood coagulation
1 ... 1798 1799 1800 1801 1802 1803 1804 1805 1806 1807 1808 1809 1810 1811 1812 1813 1814 1815 1816 1817 1818 ... 3163